Alembic Pharmaceuticals reports 23% rise in Q2 consolidated net profit

29 Oct 2019 Evaluate

Alembic Pharmaceuticals has reported results for second quarter ended September 30, 2019.

The company has reported 7.02% rise in its net profit at Rs 268.69 crore for the quarter under review as compared to Rs 251.06 crore for the same quarter in the previous year. Total income of the company increased by 3.44% at Rs 1135.18 crore for Q2FY20 as compared Rs 1097.44 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 23.09% in its net profit at Rs 246.27 crore for the quarter under review as compared to Rs 200.07 crore for the same quarter in the previous year. Total income of the company increased by 9.90% at Rs 1241.23 crore for Q2FY20 as compared Rs 1129.43 crore for the corresponding quarter previous year.

Alembic Pharma Share Price

1025.00 -1.20 (-0.12%)
06-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1529.55
Dr. Reddys Lab 6315.00
Cipla 1423.40
Zydus Lifesciences 1021.00
Lupin 1679.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.